Journal Of Pharmaceutical Sciences

Journal Of Pharmaceutical Sciences

药学杂志

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Journal Of Pharmaceutical Sciences》是由John Wiley and Sons Inc.出版社于1961年创办的英文国际期刊(ISSN: 0022-3549,E-ISSN: 1520-6017),该期刊长期致力于药物化学领域的创新研究,主要研究方向为医学-化学综合。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0676...%),以发表药物化学领域等方向的原创性研究为核心(研究类文章占比95.06%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在385篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Pharmaceutical Sciences审稿周期约为约2.3个月。该刊近年未被列入国际预警名单,年发文量约385篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 385 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MEDICINAL 药物化学 CHEMISTRY, MULTIDISCIPLINARY 化学:综合 PHARMACOLOGY & PHARMACY 药学
3区 3区 3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MEDICINAL 药物化学 CHEMISTRY, MULTIDISCIPLINARY 化学:综合 PHARMACOLOGY & PHARMACY 药学
3区 3区 3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MEDICINAL 药物化学 CHEMISTRY, MULTIDISCIPLINARY 化学:综合 PHARMACOLOGY & PHARMACY 药学
3区 3区 3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MEDICINAL 药物化学 CHEMISTRY, MULTIDISCIPLINARY 化学:综合 PHARMACOLOGY & PHARMACY 药学
3区 3区 3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MEDICINAL 药物化学 CHEMISTRY, MULTIDISCIPLINARY 化学综合 PHARMACOLOGY & PHARMACY 药学
3区 3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 31 / 72

57.6

学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q2 105 / 250

58.2

学科:PHARMACOLOGY & PHARMACY SCIE Q2 113 / 356

68.4

学科:CHEMISTRY, MEDICINAL SCIE Q2 28 / 72

61.81

学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q2 69 / 251

72.71

学科:PHARMACOLOGY & PHARMACY SCIE Q2 107 / 356

70.08

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 27 / 72

63.2

学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q2 91 / 239

62.1

学科:PHARMACOLOGY & PHARMACY SCIE Q2 92 / 352

74

学科:CHEMISTRY, MEDICINAL SCIE Q2 28 / 72

61.81

学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q2 61 / 241

74.9

学科:PHARMACOLOGY & PHARMACY SCIE Q2 98 / 353

72.38

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 29 / 72

60.4

学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q2 84 / 230

63.7

学科:PHARMACOLOGY & PHARMACY SCIE Q2 90 / 354

74.7

学科:CHEMISTRY, MEDICINAL SCIE Q2 28 / 72

61.81

学科:CHEMISTRY, MULTIDISCIPLINARY SCIE Q2 69 / 231

70.35

学科:PHARMACOLOGY & PHARMACY SCIE Q2 109 / 354

69.35

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.6 SJR:0.711 SNIP:1.045
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q2 52 / 191

73%

期刊发文

  • Hydroxypropyl-$-cyclodextrin/hyaluronic acid modified polydopamine nanoparticles co-loaded with BNN6 and epirubicin for synergistic photothermal/gas/chemotherapy of breast cance

    Author: Liu, Dexue; Asghar, Sajid; Gao, Dan; Li, Wenrong; Dong, Haijuan; Lyu, Tingmei; Chen, Zhipeng; Xiao, Yanyu

    Journal: JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 115, Issue 6, pp. -. DOI: 10.1016/j.xphs.2026.104266

  • Stabilization of supersaturation for enhanced oral absorption of a BCS II drug efonidipine hydrochloride: Eudragit® L100-55-based amorphous solid dispersion

    Author: Huang, Song; Tian, Yiqi; Gao, Jiaxin; Zhang, Yuchen; Cheng, Gang; Zou, Meijuan; Piao, Hongyu

    Journal: JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 115, Issue 6, pp. -. DOI: 10.1016/j.xphs.2026.104239

  • Preparation and evaluation of 3D-printed tacrolimus tablets based on mesoporous silica solubilizatio

    Author: Zhang, Yixin; Han, Xiaolu; Tang, Zhiqiang; Zhang, Shanning; Wang, Yisen; Zhang, Hui; Liu, Nan; Wang, Zengming; Hu, Wenhao; Zheng, Aiping

    Journal: JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 115, Issue 6, pp. -. DOI: 10.1016/j.xphs.2026.104260

  • Effect of HI-6-loaded brain-targeted metal-organic frameworks on reactivation of central nervous system enzyme

    Author: Qin, Yanhui; Li, Qian; Fan, Ning; Yang, Feng; Liu, Mengmeng; Yin, Dongfeng

    Journal: JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 115, Issue 5, pp. -. DOI: 10.1016/j.xphs.2026.104237

  • HS15-based nanotherapeutics for direct nose-to-brain delivery against central nervous system funga

    Author: Zhang, Gaoshuo; Ji, Xingwang; Zhang, Wei; Mao, Yuling

    Journal: JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 115, Issue 5, pp. -. DOI: 10.1016/j.xphs.2026.104232

  • A novel bicyclic peptide-drug conjugate of 3-fluoro-10-hydroxy-evodiamine for targeted colorectal cancer therap

    Author: Zhao, Siyuan; Chu, Chang; Li, Cuiping; Zhai, Qiaoli; Liu, Juan; Sun, Huan; Wu, Xin; Shi, Kourong; Fan, Wei

    Journal: JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 115, Issue 4, pp. -. DOI: 10.1016/j.xphs.2026.104160

  • Prediction of vancomycin exposure in patients with central nervous system infections using physiologically based pharmacokinetic modelin

    Author: Liu, Ya-xin; Kuang, Yun; Liu, Jin-long; Pei, Qi; Gong, Li-ying; Yang, Guo-ping

    Journal: JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 115, Issue 4, pp. -. DOI: 10.1016/j.xphs.2026.104192

  • Development of an active loading strategy for methylene blue in liposomes and its application in EGFR-targeted photodynamic therap

    Author: Xia, Guozi; Cao, Rui; Huang, Lizhen; Wang, Feifei; Chu, Xiaohong; Zhang, Qinxiu; Wang, Rui; Piloto-Ferrer, Janet; Yuan, Fengjiao; Li, Jun; Jia, Dianlong

    Journal: JOURNAL OF PHARMACEUTICAL SCIENCES. 2026; Vol. 115, Issue 4, pp. -. DOI: 10.1016/j.xphs.2026.104213